First Time Loading...

Immunoprecise Antibodies Ltd
XTSX:IPA

Watchlist Manager
Immunoprecise Antibodies Ltd Logo
Immunoprecise Antibodies Ltd
XTSX:IPA
Watchlist
Price: 6.5 CAD 0.78% Market Closed
Updated: May 10, 2024

Immunoprecise Antibodies Ltd
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Immunoprecise Antibodies Ltd
Operating Expenses Peer Comparison

Comparables:
ABCL
ARCH
RP
IOT

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Immunoprecise Antibodies Ltd
XTSX:IPA
Operating Expenses
-CA$18.5m
CAGR 3-Years
-37%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abcellera Biologics Inc
NASDAQ:ABCL
Operating Expenses
-$275.2m
CAGR 3-Years
-53%
CAGR 5-Years
-96%
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Operating Expenses
-CA$10m
CAGR 3-Years
-6%
CAGR 5-Years
-24%
CAGR 10-Years
-45%
Replicel Life Sciences Inc
XTSX:RP
Operating Expenses
-CA$1.7m
CAGR 3-Years
11%
CAGR 5-Years
7%
CAGR 10-Years
7%
Innovotech Inc
XTSX:IOT
Operating Expenses
-CA$1.1m
CAGR 3-Years
-10%
CAGR 5-Years
-8%
CAGR 10-Years
2%

See Also

What is Immunoprecise Antibodies Ltd's Operating Expenses?
Operating Expenses
-18.5m CAD

Based on the financial report for Apr 30, 2021, Immunoprecise Antibodies Ltd's Operating Expenses amounts to -18.5m CAD.

What is Immunoprecise Antibodies Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 3Y
-37%

Over the last year, the Operating Expenses growth was -52%. The average annual Operating Expenses growth rates for Immunoprecise Antibodies Ltd have been -37% over the past three years .